Globus Medical (GMED) Stock Forecast, Price Target & Predictions
GMED Stock Forecast
Globus Medical stock forecast is as follows: an average price target of $79.54 (represents a -6.32% downside from GMED’s last price of $84.91) and a rating consensus of 'Buy', based on 11 wall street analysts offering a 1-year stock forecast.
GMED Price Target
The average price target for Globus Medical (GMED) is $79.54 based on 1-year price targets from 11 Wall Street analysts in the past 3 months, with a price target range of $96.00 to $61.00. This represents a potential -6.32% downside from GMED's last price of $84.91.
GMED Analyst Ratings
According to 11 Wall Street analysts, Globus Medical's rating consensus is 'Buy'. The analyst rating breakdown for GMED stock is 0 'Strong Buy' (0.00%), 8 'Buy' (72.73%), 3 'Hold' (27.27%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Globus Medical Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Aug 28, 2024 | Ryan Zimmerman | BTIG | $77.00 | $71.73 | 7.35% | -9.32% |
| Aug 07, 2024 | Vik Chopra | Wells Fargo | $78.00 | $70.53 | 10.59% | -8.14% |
| Jul 15, 2024 | Drew Ranieri | Morgan Stanley | $71.00 | $71.07 | -0.10% | -16.38% |
| May 29, 2024 | Ryan Zimmerman | BTIG | $72.00 | $65.49 | 9.94% | -15.20% |
| May 20, 2024 | Matt O'Brien | Piper Sandler | $80.00 | $64.40 | 24.22% | -5.78% |
| Mar 18, 2024 | Ryan Zimmerman | BTIG | $60.00 | $51.65 | 16.17% | -29.34% |
| Sep 19, 2023 | Mathew Blackman | Stifel Nicolaus | $61.00 | $53.04 | 15.01% | -28.16% |
| Jan 06, 2023 | - | Morgan Stanley | $78.00 | $71.97 | 8.37% | -8.14% |
| Dec 20, 2022 | - | Truist Financial | $85.00 | $71.36 | 19.11% | 0.11% |
| Dec 12, 2022 | - | Wells Fargo | $82.00 | $73.13 | 12.13% | -3.43% |
The latest Globus Medical stock forecast, released on Aug 28, 2024 by Ryan Zimmerman from BTIG, set a price target of $77.00, which represents a 7.35% increase from the stock price at the time of the forecast ($71.73), and a -9.32% decrease from GMED last price ($84.91).
Globus Medical Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 1 | 6 |
| Avg Price Target | - | $77.00 | $73.00 |
| Last Closing Price | $84.91 | $84.91 | $84.91 |
| Upside/Downside | -100.00% | -9.32% | -14.03% |
In the current month, the average price target of Globus Medical stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Globus Medical's last price of $84.91. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Nov 06, 2024 | Needham | Hold | Hold | Hold |
| Nov 06, 2024 | Bank of America Securities | Underperform | Underperform | Hold |
| Oct 08, 2024 | RBC Capital | Outperform | Outperform | Hold |
| Aug 28, 2024 | BTIG | Buy | Buy | Hold |
| Aug 13, 2024 | Barclays | Overweight | Overweight | Hold |
| Jul 15, 2024 | Morgan Stanley | Equal-Weight | Equal-Weight | Hold |
| May 29, 2024 | BTIG | Buy | Buy | Hold |
| May 09, 2024 | Barclays | Overweight | Overweight | Hold |
| Mar 18, 2024 | Truist Financial | Buy | Buy | Hold |
| Mar 18, 2024 | RBC Capital | Underperform | Underperform | Hold |
Globus Medical's last stock rating was published by Needham on Nov 06, 2024. The company gave GMED a "Hold" rating, the same as its previous rate.
Globus Medical Financial Forecast
Globus Medical Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | $383.64M | $291.62M | $276.69M | $274.50M | $254.15M | $263.65M | $230.55M | $250.02M | $229.72M | $251.02M | $227.34M | $233.44M | $216.10M | $148.92M | $190.58M | $211.67M | $196.22M |
| Avg Forecast | $721.92M | $707.88M | $713.73M | $683.19M | $681.42M | $664.12M | $670.82M | $644.28M | $635.43M | $604.69M | $615.33M | $586.82M | $608.77M | $306.78M | $279.54M | $253.69M | $276.67M | $253.40M | $259.38M | $233.89M | $243.51M | $228.29M | $225.50M | $196.59M | $231.20M | $196.10M | $103.55M | $192.88M | $210.45M | $185.80M |
| High Forecast | $729.29M | $715.11M | $721.02M | $690.17M | $688.38M | $670.90M | $677.66M | $648.00M | $646.08M | $605.03M | $615.33M | $586.82M | $612.72M | $309.77M | $282.39M | $256.28M | $279.49M | $253.40M | $259.38M | $233.89M | $243.51M | $228.29M | $225.50M | $196.59M | $231.20M | $196.10M | $103.55M | $192.88M | $210.45M | $185.80M |
| Low Forecast | $716.94M | $703.00M | $708.81M | $678.48M | $676.72M | $659.54M | $666.19M | $639.98M | $630.56M | $604.34M | $615.33M | $586.81M | $598.32M | $304.18M | $277.61M | $251.94M | $274.76M | $253.40M | $259.38M | $233.89M | $243.51M | $228.29M | $225.50M | $196.59M | $231.20M | $196.10M | $103.55M | $192.88M | $210.45M | $185.80M |
| # Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 5 | 10 | 9 | 2 | 2 | 4 | 10 | 9 | 9 | 8 | 8 | 8 | 8 | 9 | 9 | 9 | 9 | 9 | 15 | 9 | 9 | 16 | 8 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.25% | 1.04% | 1.09% | 0.99% | 1.00% | 1.02% | 0.99% | 1.03% | 1.01% | 1.11% | 1.16% | 1.01% | 1.10% | 1.44% | 0.99% | 1.01% | 1.06% |
Globus Medical's average Quarter revenue forecast for Dec 23 based on 4 analysts is $608.77M, with a low forecast of $598.32M, and a high forecast of $612.72M. GMED's average Quarter revenue forecast represents a 58.68% increase compared to the company's last Quarter revenue of $383.64M (Sep 23).
Globus Medical EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 5 | 10 | 9 | 2 | 2 | 4 | 10 | 9 | 9 | 8 | 8 | 8 | 8 | 9 | 9 | 9 | 9 | 9 | 15 | 9 | 9 | 16 | 8 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | $116.58M | $66.21M | $77.02M | $71.43M | $78.19M | $83.60M | $68.20M | $38.60M | $71.20M | $68.06M | $74.35M | $79.12M | $69.43M | $-6.84M | $42.74M | $64.04M | $55.95M |
| Avg Forecast | $196.45M | $192.63M | $194.22M | $185.91M | $185.43M | $180.72M | $182.54M | $175.32M | $172.91M | $164.55M | $167.44M | $91.41M | $165.66M | $83.48M | $76.07M | $83.10M | $41.57M | $70.37M | $72.03M | $75.54M | $67.62M | $63.39M | $62.62M | $50.24M | $64.20M | $54.46M | $28.76M | $52.87M | $58.44M | $51.60M |
| High Forecast | $198.46M | $194.60M | $196.20M | $187.81M | $187.32M | $182.57M | $184.41M | $176.33M | $175.81M | $164.64M | $167.44M | $109.69M | $166.73M | $84.30M | $76.84M | $99.71M | $49.89M | $70.37M | $72.03M | $90.65M | $67.62M | $63.39M | $62.62M | $60.28M | $64.20M | $54.46M | $28.76M | $63.44M | $58.44M | $51.60M |
| Low Forecast | $195.09M | $191.30M | $192.88M | $184.63M | $184.15M | $179.47M | $181.28M | $174.15M | $171.59M | $164.45M | $167.44M | $73.12M | $162.81M | $82.77M | $75.54M | $66.48M | $33.26M | $70.37M | $72.03M | $60.43M | $67.62M | $63.39M | $62.62M | $40.19M | $64.20M | $54.46M | $28.76M | $42.29M | $58.44M | $51.60M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.40% | 0.87% | 0.93% | 1.72% | 1.11% | 1.16% | 0.90% | 0.57% | 1.12% | 1.09% | 1.48% | 1.23% | 1.27% | -0.24% | 0.81% | 1.10% | 1.08% |
4 analysts predict GMED's average Quarter EBITDA for Dec 23 to be $165.66M, with a high of $166.73M and a low of $162.81M. This is 42.10% upper than Globus Medical's previous annual EBITDA (Sep 23) of $116.58M.
Globus Medical Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 5 | 10 | 9 | 2 | 2 | 4 | 10 | 9 | 9 | 8 | 8 | 8 | 8 | 9 | 9 | 9 | 9 | 9 | 15 | 9 | 9 | 16 | 8 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | $998.00K | $57.71M | $49.13M | $50.06M | $47.43M | $54.59M | $38.08M | $15.11M | $47.21M | $41.55M | $45.33M | $52.96M | $44.22M | $-20.84M | $25.95M | $45.53M | $38.31M |
| Avg Forecast | $140.77M | $136.82M | $137.99M | $130.69M | $123.01M | $117.49M | $119.49M | $108.32M | $101.98M | $89.34M | $93.53M | $50.98M | $80.66M | $74.55M | $81.54M | $46.35M | $16.27M | $70.92M | $73.08M | $42.14M | $64.71M | $61.87M | $60.94M | $30.63M | $69.64M | $41.80M | $-15.59M | $32.09M | $71.63M | $57.88M |
| High Forecast | $142.64M | $138.63M | $139.83M | $132.42M | $124.65M | $119.05M | $121.07M | $115.09M | $115.23M | $89.47M | $93.56M | $61.18M | $84.76M | $80.07M | $82.62M | $55.62M | $19.52M | $70.92M | $73.08M | $50.56M | $64.71M | $61.87M | $60.94M | $36.75M | $69.64M | $41.80M | $-15.59M | $38.51M | $71.63M | $57.88M |
| Low Forecast | $139.51M | $135.59M | $136.75M | $129.52M | $121.91M | $116.44M | $118.42M | $104.25M | $92.71M | $89.21M | $93.50M | $40.79M | $77.92M | $70.40M | $80.81M | $37.08M | $13.02M | $70.92M | $73.08M | $33.71M | $64.71M | $61.87M | $60.94M | $24.50M | $69.64M | $41.80M | $-15.59M | $25.68M | $71.63M | $57.88M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.01% | 0.71% | 1.06% | 3.08% | 0.67% | 0.75% | 0.90% | 0.23% | 0.76% | 0.68% | 1.48% | 0.76% | 1.06% | 1.34% | 0.81% | 0.64% | 0.66% |
Globus Medical's average Quarter net income forecast for Dec 23 is $80.66M, with a range of $77.92M to $84.76M. GMED's average Quarter net income forecast represents a 7981.88% increase compared to the company's last Quarter net income of $998.00K (Sep 23).
Globus Medical SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 5 | 10 | 9 | 2 | 2 | 4 | 10 | 9 | 9 | 8 | 8 | 8 | 8 | 9 | 9 | 9 | 9 | 9 | 15 | 9 | 9 | 16 | 8 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | $156.21M | $120.07M | $122.42M | $118.08M | $106.58M | $106.72M | $100.75M | $106.56M | $96.44M | $107.25M | $97.89M | $96.83M | $93.30M | $84.13M | $97.31M | $95.54M | $92.08M |
| Avg Forecast | $311.87M | $305.80M | $308.33M | $295.14M | $294.37M | $286.90M | $289.79M | $278.33M | $274.50M | $261.22M | $265.82M | $134.87M | $262.99M | $132.53M | $120.76M | $122.61M | $114.77M | $109.47M | $112.05M | $111.47M | $105.20M | $98.62M | $97.42M | $66.14M | $99.88M | $84.72M | $44.74M | $120.36M | $90.91M | $80.27M |
| High Forecast | $315.05M | $308.93M | $311.48M | $298.15M | $297.38M | $289.83M | $292.75M | $279.94M | $279.10M | $261.37M | $265.82M | $161.85M | $264.69M | $133.82M | $121.99M | $147.13M | $137.73M | $109.47M | $112.05M | $133.76M | $105.20M | $98.62M | $97.42M | $79.37M | $99.88M | $84.72M | $44.74M | $144.44M | $90.91M | $80.27M |
| Low Forecast | $309.72M | $303.69M | $306.20M | $293.10M | $292.34M | $284.92M | $287.79M | $276.47M | $272.40M | $261.07M | $265.82M | $107.90M | $258.47M | $131.40M | $119.93M | $98.09M | $91.82M | $109.47M | $112.05M | $89.17M | $105.20M | $98.62M | $97.42M | $52.91M | $99.88M | $84.72M | $44.74M | $96.29M | $90.91M | $80.27M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.18% | 0.99% | 1.00% | 1.03% | 0.97% | 0.95% | 0.90% | 1.01% | 0.98% | 1.10% | 1.48% | 0.97% | 1.10% | 1.88% | 0.81% | 1.05% | 1.15% |
Globus Medical's average Quarter SG&A projection for Dec 23 is $262.99M, based on 4 Wall Street analysts, with a range of $258.47M to $264.69M. The forecast indicates a 68.36% rise compared to GMED last annual SG&A of $156.21M (Sep 23).
Globus Medical EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 5 | 10 | 9 | 2 | 2 | 4 | 10 | 9 | 9 | 8 | 8 | 8 | 8 | 9 | 9 | 9 | 9 | 9 | 15 | 9 | 9 | 16 | 8 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | $0.01 | $0.57 | $0.49 | $0.50 | $0.48 | $0.54 | $0.37 | $0.15 | $0.47 | $0.41 | $0.45 | $0.54 | $0.45 | $-0.21 | $0.26 | $0.46 | $0.39 |
| Avg Forecast | $1.02 | $0.99 | $1.00 | $0.95 | $0.89 | $0.85 | $0.87 | $0.78 | $0.74 | $0.65 | $0.68 | $0.57 | $0.58 | $0.54 | $0.59 | $0.51 | $0.56 | $0.52 | $0.53 | $0.47 | $0.47 | $0.45 | $0.44 | $0.37 | $0.51 | $0.31 | $-0.11 | $0.38 | $0.52 | $0.42 |
| High Forecast | $1.03 | $1.00 | $1.01 | $0.96 | $0.90 | $0.86 | $0.88 | $0.83 | $0.83 | $0.65 | $0.68 | $0.57 | $0.61 | $0.58 | $0.60 | $0.52 | $0.57 | $0.52 | $0.53 | $0.47 | $0.47 | $0.45 | $0.44 | $0.37 | $0.51 | $0.31 | $-0.11 | $0.38 | $0.52 | $0.42 |
| Low Forecast | $1.01 | $0.98 | $0.99 | $0.94 | $0.88 | $0.84 | $0.86 | $0.76 | $0.67 | $0.65 | $0.68 | $0.56 | $0.56 | $0.51 | $0.59 | $0.50 | $0.55 | $0.52 | $0.53 | $0.47 | $0.47 | $0.45 | $0.44 | $0.37 | $0.51 | $0.31 | $-0.11 | $0.38 | $0.52 | $0.42 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.02% | 0.97% | 0.96% | 0.89% | 0.93% | 1.01% | 0.79% | 0.32% | 1.04% | 0.92% | 1.23% | 1.06% | 1.47% | 1.84% | 0.69% | 0.88% | 0.92% |
According to 4 Wall Street analysts, Globus Medical's projected average Quarter EPS for Dec 23 is $0.58, with a low estimate of $0.56 and a high estimate of $0.61. This represents a 5742.10% increase compared to GMED previous annual EPS of $0.01 (Sep 23).
Globus Medical Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| NVRO | Nevro | $4.36 | $32.72 | 650.46% | Hold |
| NVCR | NovoCure | $17.09 | $68.92 | 303.28% | Hold |
| ATEC | Alphatec | $10.21 | $16.94 | 65.92% | Buy |
| IRTC | iRhythm | $73.90 | $121.17 | 63.96% | Buy |
| LIVN | LivaNova | $51.70 | $70.50 | 36.36% | Buy |
| CNMD | CONMED | $71.71 | $96.00 | 33.87% | Buy |
| NARI | Inari Medical | $49.75 | $66.11 | 32.88% | Buy |
| BRKR | Bruker | $56.22 | $73.75 | 31.18% | Buy |
| INSP | Inspire Medical Systems | $186.19 | $239.55 | 28.66% | Buy |
| OFIX | Orthofix Medical | $18.68 | $24.00 | 28.48% | - |
| PODD | Insulet | $262.00 | $274.00 | 4.58% | Buy |
| ITGR | Integer | $135.88 | $138.00 | 1.56% | Buy |
| GMED | Globus Medical | $84.91 | $79.54 | -6.32% | Buy |
| GKOS | Glaukos | $140.83 | $123.44 | -12.35% | Buy |